Joshua Weir
Radiation Oncology · Wichita, KSNPI 1790102671
Payments from drug & device makers
Across 128 payments — averaging $44.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$2K
- AstraZeneca$1K
- Novartis$385
- Blue Earth Diagnostics$231
- Pfizer$222
- Myriad Genetic Laboratories, Inc.$176
- plus $1K from 21 others
What the payments were for
- Consulting fees$1,72031%
- Food & beverage$3,81368%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $2,047 |
| AstraZeneca | 27 | $1,294 |
| Novartis | 17 | $385 |
| Blue Earth Diagnostics | 13 | $231 |
| Pfizer | 11 | $222 |
| Myriad Genetic Laboratories, Inc. | 10 | $176 |
| Accord Healthcare, Inc. | 5 | $150 |
| Dendreon Pharmaceuticals LLC | 5 | $138 |
| Eisai Inc. | 1 | $125 |
| Siemens Medical Solutions USA, Inc. | 3 | $119 |
| Ferring Pharmaceuticals Inc. | 1 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| Boston Scientific | 4 | $94 |
| Progenics Pharmaceuticals, Inc. | 4 | $84 |
| Johnson & Johnson | 2 | $47 |
| Tactile Systems Technology Inc | 2 | $42 |
| Pharmaand GmbH | 2 | $38 |
| Tolmar, Inc. | 2 | $38 |
| Tolmar Pharmaceuticals, Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Teleflex LLC | 1 | $24 |
| Urogen Pharma, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $18 |
| AbbVie | 1 | $17 |
| Novocure Inc. | 1 | $17 |
| Telix Pharmaceuticals | 1 | $16 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,633 in reported general payments places this provider in the 85th percentile of 54 radiation oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 342 | $2,260 |
| Lidocaine Hcl ViscousLidocaine Hcl | 20 | $242 |
| Oxybutynin Chloride | 13 | $219 |
| Methylprednisolone | 21 | $174 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Wichita
- David BryantWichita$15K
- Ellen CookeWichita$3K
- Grant RineWichita$2K
- Salman HasanWichita$876
- Angela ZhuWichita$790
- Andrew HuntWichita$508
- Barbara LuderWichita$88
- Ronald ChenKansas City$2.4M
- David AkhavanKansas City$818K
- Xinglei ShenKansas City$777K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.